Tissue proteomics outlines AGR2 AND LOX5 as markers for biochemical recurrence of prostate cancer

Although many patients are cured from prostate cancer (PCa) by surgery only, there are still patients who will experience rising prostate-specific antigen (PSA) levels after surgery, a condition known as biochemical recurrence (BCR). Novel protein prognostic markers in PCa tissue might enable findin...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Blanco, Giovanny, Zeneyedpour, Lona, Duijvesz, Diederick, Hoogland, A. Marije, Verhoef, Esther I., Kweldam, Charlotte F., Burgers, Peter C., Smitt, Peter Sillevis, Bangma, Chris H., Jenster, Guido, van Leenders, Geert J.L.H., Dekker, Lennard J.M., Luider, Theo M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284859/
https://www.ncbi.nlm.nih.gov/pubmed/30559929
http://dx.doi.org/10.18632/oncotarget.26342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284859/
https://www.ncbi.nlm.nih.gov/pubmed/30559929
http://dx.doi.org/10.18632/oncotarget.26342

Ejemplares similares